TY  - THES
A1  - Schewe, Victoria Kristina
T1  - Mikrokernbildung in Mundschleimhautzellen von Patienten mit Kopf-Hals-Tumoren während Radio-/Radiochemotherapie
T1  - Micronucleus formation kinetics in buccal mucosa cells of head and neck cancer patients undergoing radio-/radiochemotherapy
N2  - Das Ziel der vorliegenden Arbeit war die Mikrokernbildung in Mundschleimhautzellen von 35 Patienten mit Kopf-Hals-Tumoren während einer sechswöchigen Radio-/Radiochemotherapie und sechs Wochen danach darzustellen. Die Ergebnisse der vorliegenden Arbeit zeigten, dass Patienten mit Kopf-Hals-Tumoren im Vergleich zu gesunden Probanden erhöhte Mikrokernraten aufwiesen. Ebenfalls konnte gezeigt werden, dass es zu einer vermehrten Bildung von Mikrokernen während einer sechswöchigen Radio-/Radiochemotherapie kam. Nach Therapiebeendigung sanken die Werte nach drei bis sechs Wochen und lagen unter dem Ausgangswert, in dem Bereich von spontan entstehenden Mikrokernen. In Bezug auf die Tumorgröße konnte nur in der zweiten Woche ein signifikanter Unterschied in der Mikrokernrate zwischen T1- und T4-Stadium beobachtet werden. Es konnte keine Korrelation zwischen einer zusätzlich verabreichten Chemotherapie, Grading des Tumors, Alter sowie Geschlecht der Patienten und einem Anstieg der Mikrokernrate festgestellt werden.
N2  - In the present Study, normal tissue buccal mucosa cells from 35 patients with head and neck cancer were analyzed for formation of micronuclei during a 6-week radio-/radiochemotherapy and 6 weeks afterwards. The results showed that patients with head and neck cancer had increased micronucleus rates compared to healthy test persons. It could also be observed that there was an increased formation of micronuclei during a 6-week radio-/radiochemotherapy. After the end of therapy, the values decreased after three to six weeks. The tumor size showed in the second week a significant difference in the micronucleus rate between T1 and T4 stage. Age, gender, and tumor stage did not have an influence on the micronuclei formation kinetics.
KW  - Kleinkern
KW  - Mundschleimhaut
KW  - Strahlentherapie
KW  - Chemotherapie
KW  - Hals-Nasen-Ohren-Tumor
KW  - Mikrokern
KW  - micronucleus
KW  - Kopf-Hals-Tumor
KW  - head and neck cancer
KW  - Mundschleimhaut
KW  - buccal mucosa
KW  - Bestrahlung
KW  - radiation
Y1  - 2020
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-215354
ER  - 
TY  - JOUR
A1  - Fathy, Moustafa
A1  - Fawzy, Michael Atef
A1  - Hintzsche, Henning
A1  - Nikaido, Toshio
A1  - Dandekar, Thomas
A1  - Othman, Eman M.
T1  - Eugenol exerts apoptotic effect and modulates the sensitivity of HeLa cells to cisplatin and radiation
JF  - Molecules
N2  - Eugenol is a phytochemical present in different plant products, e.g., clove oil. Traditionally, it is used against a number of different disorders and it was suggested to have anticancer activity. In this study, the activity of eugenol was evaluated in a human cervical cancer (HeLa) cell line and cell proliferation was examined after treatment with various concentrations of eugenol and different treatment durations. Cytotoxicity was tested using lactate dehydrogenase (LDH) enzyme leakage. In order to assess eugenol’s potential to act synergistically with chemotherapy and radiotherapy, cell survival was calculated after eugenol treatment in combination with cisplatin and X-rays. To elucidate its mechanism of action, caspase-3 activity was analyzed and the expression of various genes and proteins was checked by RT-PCR and western blot analyses. Eugenol clearly decreased the proliferation rate and increased LDH release in a concentration- and time-dependent manner. It showed synergistic effects with cisplatin and X-rays. Eugenol increased caspase-3 activity and the expression of Bax, cytochrome c (Cyt-c), caspase-3, and caspase-9 and decreased the expression of B-cell lymphoma (Bcl)-2, cyclooxygenase-2 (Cox-2), and interleukin-1 beta (IL-1β) indicating that eugenol mainly induced cell death by apoptosis. In conclusion, eugenol showed antiproliferative and cytotoxic effects via apoptosis and also synergism with cisplatin and ionizing radiation in the human cervical cancer cell line.
KW  - eugenol
KW  - HeLa cells
KW  - cisplatin
KW  - radiation
KW  - apoptosis
Y1  - 2019
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-193227
SN  - 1420-3049
VL  - 24
IS  - 21
ER  -